✦ LIBER ✦

PMH23 COST-EFFECTIVENESS OF OLANZAPINE VERSUS GENERIC RISPERIDONE AND OTHER ANTIPSYCHOTICS IN STANDARD ORAL FORMULATIONS IN PATIENTS WITH SCHIZOPHRENIA IN THE US

✍ Scribed by H Ascher-Svanum; NM Furiak; RW Klein; LJ Smolen; B Zhu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

COST-EFFECTIVENESS OF GENERIC RISPERIDON

✍ Robert Klein; Haya Ascher-Svanum; Nicolas Furiak; Lee Smolen; Anthony Lawson; Da 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

PMH14 THE COST-EFFECTIVENESS OF QUETIAPI

✍ G Meier 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PMH31 Cost-Effectiveness of Long-Acting

✍ T. Dilla; P. O'Donohoe; J. Möller; M. Álvarez; J. Sacristán; L. San; M. Happich; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMH39 BASELINE COMPARISON OF PATIENTS WI

✍ P Mulani; PJ Gibson; J McCombs 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Safety and effectiveness of olanzapine v

✍ J.C. Gómez; J.A. Sacristán; P.R. Carrasco; C.A. Saiz; E.F. Carbonell 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Safety and effectiveness of olanzapine v

✍ J.C. Gomez; J.A. Sacristan; P.R. Carrasco; C.A. Saiz; E.F. Carbonell 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 97 KB